| Cat.#: 28092 |
| Product Name: Anti-FCRL5(Cevostamab Without Anti-CD3 Portion) Monoclonal Antibody |
| Synonyms: BXMAS1;CD307;CD307e;FCRH5;IRTA2;PRO820 |
| Description: Anti-FCRL5(cevostamab without anti-CD3 portion) Monoclonal Antibody |
| Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Applications: ELISA; Flow Cyt |
| Recommended Dilutions: ELISA 1:5000-10000; Flow Cyt 1:100 |
| Host Species: Humanized |
| Isotype: IgG1 |
| Purification: Purified from cell culture supernatant by affinity chromatography |
| Species Reactivity: Human FCRL5 |
| Constituents: Lyophilized from sterile PBS, pH 7.4. 5 % – 8% trehalose is added as protectants before lyophilization. |
| Storage & Shipping: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). |
Figure 1. ELISA plate pre-coated by 2 µg/mL (100 µl/well) Human FCRL5 Protein, His Tag 11421 can bind Anti-FCRL5 Neutralizing antibody ( 28092) in a linear range of 0.61-39.06 ng/mL. | 
Figure 2. Flow cytometry analysis with 1 µg/mL Anti-FCRL5 (cevostamab biosimilar) mAb (28092) on Expi293 cells transfected with Human FCRL5 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram). |
|
